Biblio

Export 168 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
D. A. Gimbel, Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., and Strittmatter, S. M., “Memory impairment in transgenic Alzheimer mice requires cellular prion protein.”, J Neurosci, vol. 30, no. 18, pp. 6367-74, 2010.
J. F. - M. Gilmartin-Thomas, McNeil, J., Powell, A., Malone, D. T., Wolfe, R., Larson, I. C., O'Reilly, C. L., Kirkpatrick, C. M., Kipen, E., Petrovich, T., and J Bell, S., “Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 867-876, 2018.
S. Gill, Mouches, P., Hu, S., Rajashekar, D., MacMaster, F. P., Smith, E. E., Forkert, N. D., and Ismail, Z., “Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.”, J Alzheimers Dis, vol. 75, no. 1, pp. 277-288, 2020.
T. Gilbert, Roche, S., Blond, E., Bar, J. - Y., Drai, J., Cuerq, C., Haution-Bitker, M., Ecochard, R., and Bonnefoy, M., “Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1255-1264, 2018.
M. José Gil, Manzano, M. Sagrario, Cuadrado, M. Luz, Fernández, C., Góméz, E., Matesanz, C., Calero, M., and Rábano, A., “Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1109-1117, 2018.
R. Gil and Arroyo-Anlló, E. M., “Alzheimer's Disease and Face Masks in Times of COVID-19.”, J Alzheimers Dis, vol. 79, no. 1, pp. 9-14, 2021.
L. M. Giil, Vedeler, C. A., Kristoffersen, E. K., Nordrehaug, J. Erik, Heidecke, H., Dechend, R., Schulze-Forster, K., Muller, D. N., von Goetze, V. S., Cabral-Marques, O., Riemekasten, G., Vogelsang, P., Nygaard, S., Lund, A., and Aarsland, D., “Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.”, J Alzheimers Dis, vol. 59, no. 3, pp. 929-939, 2017.
L. Melvaer Giil, Midttun, Ø., Refsum, H., Ulvik, A., Advani, iv, R., A Smith, D., and Ueland, P. Magne, “Kynurenine Pathway Metabolites in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 495-504, 2017.
L. M. Giil, Aarsland, D., Hellton, K., Lund, A., Heidecke, H., Schulze-Forster, K., Riemekasten, G., Vik-Mo, A. Osland, Kristoffersen, E. K., Vedeler, C. A., and Nordrehaug, J. Erik, “Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study.”, J Alzheimers Dis, vol. 64, no. 3, pp. 761-774, 2018.
V. Giannouli, Stamovlasis, D., and Tsolaki, M., “Exploring the Role of Cognitive Factors in a New Instrument for Elders' Financial Capacity Assessment.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1579-1594, 2018.
M. Pia Giannoccaro, Bartoletti-Stella, A., Piras, S., Casalena, A., Oppi, F., Ambrosetto, G., Montagna, P., Liguori, R., Parchi, P., and Capellari, S., “The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.”, J Alzheimers Dis, vol. 62, no. 2, pp. 687-697, 2018.
G. Giaccone, “The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.”, J Alzheimers Dis, 2015.
R. Ghidoni, Squitti, R., Siotto, M., and Benussi, L., “Innovative Biomarkers for Alzheimer's Disease: Focus on the Hidden Disease Biomarkers.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1507-1518, 2018.
C. Gervaise-Henry, Watfa, G., Albuisson, E., Kolodziej, A., Dousset, B., Olivier, J. - L., Jonveaux, T. Rivasseau, and Malaplate-Armand, C., “Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting.”, J Alzheimers Dis, vol. 57, no. 2, pp. 437-445, 2017.
E. Christiane Gertje, Pluta, J., Das, S., Mancuso, L., Kliot, D., Yushkevich, P., and Wolk, D., “Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1027-1037, 2016.
A. Gerstenecker, Hoagey, D. A., Marson, D. C., and Kennedy, K. M., “White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 537-547, 2017.
L. Gerritsen, Twait, E. L., Jonsson, P. V., Gudnason, V., Launer, L. J., and Geerlings, M. I., “Depression and Dementia: The Role of Cortisol and Vascular Brain Lesions. AGES-Reykjavik Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1677-1687, 2021.
A. A. J. Gerritsen, Bakker, C., Verhey, F. R. J., Bor, H., Pijnenburg, Y. A. L., de Vugt, M. E., and Koopmans, R. T. C. M., “The Progression of Dementia and Cognitive Decline in a Dutch 2-Year Cohort Study of People with Young-Onset Dementia.”, J Alzheimers Dis, vol. 63, no. 1, pp. 343-351, 2018.
M. Gentreau, Reynes, C., Sabatier, R., Maller, J. J., Meslin, C., Deverdun, J., Le Bars, E., Raymond, M., Berticat, C., and Artero, S., “Glucometabolic Changes Are Associated with Structural Gray Matter Alterations in Prodromal Dementia.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1293-1302, 2022.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., “Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
S. Gelman, Palma, J., Tombaugh, G., and Ghavami, A., “Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 195-208, 2018.
F. Gelfo, Cutuli, D., Nobili, A., De Bartolo, P., D'Amelio, M., Petrosini, L., and Caltagirone, C., “Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1505-1518, 2017.
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, “Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
S. Ge, Kitamura, T., Zha, L., Komatsu, M., Komukai, S., Murata, F., Maeda, M., Gon, Y., Kimura, Y., Kiyohara, K., Sobue, T., and Fukuda, H., “Association of Statin Use with Dementia Risk Among Older Adults in Japan: A Nested Case-Control Study Using the LIFE Study.”, J Alzheimers Dis, vol. 100, no. 3, pp. 987-998, 2024.
S. Gazzina, Archetti, S., Alberici, A., Bonomi, E., Cosseddu, M., Di Lorenzo, D., Padovani, A., and Borroni, B., “Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1185-1189, 2017.

Pages